Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-011080

CEO, CFO, Director gave up 435 shares (to pay taxes)

  • CEO, CFO, Director acquired 1,309 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Finley John David · CEO, CFO, Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-03 Exercise or conversion : show line 1 in the form +1,309 4,283 D
2023-04-03 Shares withheld for taxes : show line 2 in the form −435 $2.01 $874 3,848 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,309 3,927 D
Loading xslF345X04/ownership.xml…